Related Experiment Video
Updated: Jul 25, 2026
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Genetic and gene expression signatures in multiple sclerosis.
Nikolaos A Patsopoulos1, Philip L De Jager2
1Systems Biology and Computer Science Program, Ann Romney Center for Neurological Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA/Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA/Harvard Medical School, Boston, MA, USA/Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
Multiple sclerosis (MS) is a heritable neurological disease. Genetic and genomic research, including single-cell transcriptomics, offers potential for earlier and improved MS diagnosis.
Area of Science:
- Neuroimmunology
- Genetics
- Genomics
Background:
- Multiple sclerosis (MS) demonstrates significant heritability, with over 200 genetic associations identified.
- Current genetic knowledge explains approximately half of MS heritability, leaving room for further discovery.
- Advancements in genomics and single-cell technologies provide new avenues for understanding disease mechanisms.
Purpose of the Study:
- To explore the potential of integrating genetic and genomic data for improving multiple sclerosis diagnosis.
- To investigate how advancements in high-throughput technologies can aid in early MS detection.
- To assess the current state of MS genetics and its diagnostic implications.
Main Methods:
- Genome-wide association studies (GWAS) for identifying genetic risk factors.
- Single-cell transcriptome analysis to characterize cellular changes.
- Integration of genetic, genomic, and deep phenotyping data from patient cohorts.
Main Results:
- Over 200 genome-wide significant genetic associations for MS have been identified.
- Genetics currently accounts for up to 50% of MS heritability.
- Single-cell transcriptomics offers insights into early disease markers.
Conclusions:
- Leveraging genetic and genomic data, alongside advanced technologies, holds significant promise for enhancing MS diagnosis.
- Early detection of transcriptional changes in key cells could serve as diagnostic indicators.
- Further research integrating multi-omics data and deep phenotyping is crucial for clinical translation.
